Changes in Treatment Patterns and Their Influence on the Outcome of Systemic Sclerosis-interstitial Lung Disease (SSc-ILD) Patients: An EUSTAR Analysis

被引：0

作者：

Campochiaro, Corrado ^{[1
]}

Truchetet, Marie-Elise ^{[2
]}

Vonk, Madelon ^{[3
]}

Cuomo, Giovanna ^{[4
]}

Ananieva, Lidia P. ^{[5
]}

Hachulla, Eric ^{[6
]}

Smith, Vanessa ^{[7
]}

Gheorghiu, Ana Maria ^{[8
]}

Becvar, Radim ^{[9
]}

Hunzelmann, Nicolas ^{[10
]}

Furst, Daniel ^{[11
,12
]}

Ortiz-Santamaria, Vera

Carreira, Patricia ^{[13
]}

Del Galdo, Francesco ^{[14
]}

Cerinic, Marco Matucci ^{[15
]}

Hoffmann-Vold, Anna Maria ^{[16
]}

机构：

[1] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Disease, Milan, Italy

[2] Bordeaux Univ Hosp, Bordeaux, France

[3] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands

[4] Luigi Vanvitelli Univ Campania, Dept Precis Med, Naples, Italy

[5] VA Nasonova Res Inst Rheumatol Russian Federat, Moscow, Russia

[6] Univ Lille, Lille, France

[7] Ghent Univ Hosp, Ghent, Belgium

[8] Ion Cantacuzino Clin Hosp, Dept Internal Med & Rheumatol, Bucharest, Romania

[9] Charles Univ Prague, Inst Rheumatol, Dept Rheumatol, Fac Med 1, Prague, Czech Republic

[10] Univ Ksln, Ksln, Germany

[11] Univ Calif Los Angeles, Los Angeles, CA USA

[12] Univ Granollers, Granollers, Spain

[13] Hosp Univ 12 Octubre, Madrid, Spain

[14] Univ Leeds, Leeds Inst Rheumat & Muskuloskeletal Med, Leeds, England

[15] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy

[16] Oslo Univ Hosp, Dept Rheumatol, Oslo, Norway

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0662

引用

页码：1323 / 1325

页数：3

共 50 条

[41] Examining Clinical Characteristics of Patients with Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) and Myositis Antibodies: A Retrospective Case Series
Pandya, K.
Raddawi, M.
D'Silva, K. M.
Montesi, S. B.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[42] HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) AND SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN FRANCE.
Nasser, M.
Rabiega, P.
Boussel, L.
Si-Mohamed, S.
Barbet, V
Marque, S.
Massol, J.
Revel, D.
Thivolet-Bejui, F.
Chalabreysse, L.
Maucort-Boulch, D.
Jouneau, S.
Hachulla, E.
Cottin, V
VALUE IN HEALTH, 2020, 23 : S717 - S718
[43] Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI)
Clukers, Johan
Homer, Kate
Lanclus, Maarten
Belmans, Dennis
Van Holsbeke, Cedric
De Backer, Wifried
De Backer, Jan W.
Khanna, Dinesh
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[44] BASELINE CHARACTERISTICS OF PATIENTS WITH IMPROVEMENT OR PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) DURING THE SENSCIS TRIAL
Hoffmann-Vold, A. M.
Hachulla, E.
Herrick, A.
Moua, T.
Riemekasten, G.
Vonk, M.
James, A.
Alves, M.
Distler, O.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 720 - 720
[45] Effect of Nintedanib in Patients with Systemic Sclerosis- Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline
Wells, A. U.
Highland, K. B.
Glaeser, S.
Nunes, H.
Song, J. W.
Wuyts, W. A.
Stock, C.
Alves, M.
Padilla, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[46] Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib: Sub-Study of the SENSCIS Trial
Humphries, Stephen
Hachulla, Eric
Hamblin, Mark
Ogura, Takashi
Wormanns, Dag
Ittrich, Carina
Risse, Frank
Alves, Margarida
Gahlemann, Martina
Lynch, David
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[47] Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib: Sub-Study of the SENSCIS Trial
Bonella, F.
Humphries, S.
Hachulla, E.
Hamblin, M.
Ogura, T.
Wormanns, D.
Ittrich, C.
Risse, F.
Alves, M.
Gahlemann, M.
Lynch, D. A.
PNEUMOLOGIE, 2021, 75 : S24 - S25
[48] CHANGE IN CXCL4 LEVELS MAY PREDICT TREATMENT RESPONSE IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
Volkmann, E.
Tashkin, D.
Elashoff, R.
Tseng, C. -H.
Khanna, D.
Mayes, M.
Charles, J.
Clements, P.
Roth, M.
Furst, D.
Assassi, S.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 535 - 535
[49] Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Kreuter, Michael
Del Galdo, Francesco
Miede, Corinna
Khanna, Dinesh
Wuyts, Wim A.
Hummers, Laura K.
Alves, Margarida
Schoof, Nils
Stock, Christian
Allanore, Yannick
ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
[50] Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Michael Kreuter
Francesco Del Galdo
Corinna Miede
Dinesh Khanna
Wim A. Wuyts
Laura K. Hummers
Margarida Alves
Nils Schoof
Christian Stock
Yannick Allanore
Arthritis Research & Therapy, 24

← 1 2 3 4 5 →